| An annotated corpus from biomedical articles to construct a drug-food interaction database S Kim, Y Choi, JH Won, JM Oh, H Lee Journal of Biomedical Informatics 126, 103985, 2022 | 5 | 2022 |
| A population pharmacokinetic‐pharmacodynamic model of YH12852, a highly selective 5‐hydroxytryptamine 4 receptor agonist, in healthy subjects and patients with functional … S Kim, HA Lee, SB Jang, H Lee CPT: Pharmacometrics & Systems Pharmacology 10 (8), 902-913, 2021 | 2 | 2021 |
| Automatic Extraction of Comprehensive Drug Safety Information from Adverse Drug Event Narratives in the Korea Adverse Event Reporting System Using Natural Language Processing … S Kim, T Kang, TK Chung, Y Choi, YS Hong, K Jung, H Lee Drug Safety 46 (8), 781-795, 2023 | 1 | 2023 |
| CReSE: Benchmark Data and Automatic Evaluation Framework for Recommending Eligibility Criteria from Clinical Trial Information S Kim, JH Won, D Lee, R Luo, L Wu, T Qin, H Lee Findings of the Association for Computational Linguistics: EACL 2024, 2243-2273, 2024 | | 2024 |
| Deep learning-based long-term risk evaluation of incident type 2 diabetes using electrocardiogram in a non-diabetic population: a retrospective, multicentre study J Kim, HL Yang, SH Kim, S Kim, J Lee, J Ryu, K Kim, Z Kim, G Ahn, ... Eclinicalmedicine 68, 2024 | | 2024 |
| Revisiting Machine-Learning based Drug Repurposing: Drug Indications Are Not a Right Prediction Target S Kim, JH Won, DSU Lee, LW Renqian Luo, Y Xia, T Qin, H Lee Proceedings of the Conference on Health, Inference, and Learning 209, 100-116, 2023 | | 2023 |
| A critical review of the United States regulatory pathways for determining the equivalence of efficacy between CT-P13 and original infliximab (Remicade®) S Kim, S Kim, H Lee Drug Design, Development and Therapy, 2831-2840, 2020 | | 2020 |
Howard LeeSeoul National UniversityVerified email at snu.ac.kr
